Brief: Theratechnologies Receives FDA Approval Of Prior Approval Supplement (Pas) For Egrifta Sv® Sbla

Theratechnologies

08/04/2025 12:02

April 8 (Reuters) - Theratechnologies Inc TH.TO:

THERATECHNOLOGIES RECEIVES FDA APPROVAL OF PRIOR APPROVAL SUPPLEMENT (PAS) FOR EGRIFTA SV® SBLA

THERATECHNOLOGIES: FDA ACTION ALLOWS FOR UNRESTRICTED DISTRIBUTION OF EGRIFTA SV, REMOVING UNCERTAINTY ABOUT ALL MANUFACTURED BATCHES

Source text: ID:nGNX1T6R7w

Further company coverage: TH.TO

 (((( Reuters.briefs@thomsonreuters.com ;));))